1. Home
  2. SXI vs LGND Comparison

SXI vs LGND Comparison

Compare SXI & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXI
  • LGND
  • Stock Information
  • Founded
  • SXI 1955
  • LGND 1987
  • Country
  • SXI United States
  • LGND United States
  • Employees
  • SXI N/A
  • LGND N/A
  • Industry
  • SXI Industrial Machinery/Components
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • SXI Industrials
  • LGND Health Care
  • Exchange
  • SXI Nasdaq
  • LGND Nasdaq
  • Market Cap
  • SXI 2.5B
  • LGND 2.3B
  • IPO Year
  • SXI N/A
  • LGND 1992
  • Fundamental
  • Price
  • SXI $190.99
  • LGND $111.89
  • Analyst Decision
  • SXI Strong Buy
  • LGND Strong Buy
  • Analyst Count
  • SXI 3
  • LGND 6
  • Target Price
  • SXI $227.00
  • LGND $145.00
  • AVG Volume (30 Days)
  • SXI 54.3K
  • LGND 124.3K
  • Earning Date
  • SXI 01-30-2025
  • LGND 02-25-2025
  • Dividend Yield
  • SXI 0.67%
  • LGND N/A
  • EPS Growth
  • SXI N/A
  • LGND 160.46
  • EPS
  • SXI 6.09
  • LGND 2.47
  • Revenue
  • SXI $706,325,000.00
  • LGND $152,422,000.00
  • Revenue This Year
  • SXI $12.37
  • LGND $26.86
  • Revenue Next Year
  • SXI $9.27
  • LGND $14.95
  • P/E Ratio
  • SXI $31.10
  • LGND $45.27
  • Revenue Growth
  • SXI N/A
  • LGND N/A
  • 52 Week Low
  • SXI $141.90
  • LGND $67.72
  • 52 Week High
  • SXI $212.66
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • SXI 51.38
  • LGND 50.22
  • Support Level
  • SXI $175.00
  • LGND $102.79
  • Resistance Level
  • SXI $187.40
  • LGND $112.61
  • Average True Range (ATR)
  • SXI 3.75
  • LGND 4.01
  • MACD
  • SXI 0.54
  • LGND 0.39
  • Stochastic Oscillator
  • SXI 88.93
  • LGND 87.67

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: